Mine Health and Safety Act, 1996 (Act No. 29 of 1996)

Notices

Guidance Note for the Implementation of HIV Self-Testing in the South African Mining Industry

Part A : The Guidance Note

4. Definitions and Acronyms

Purchase cart Previous page Return to chapter overview Next page

 

4.1. "ART"

means antiretroviral therapy.

 

4.2. "Conventional facility-based HIV testing"

means a process where a patient in a clinic, or any facility offering health services, is offered HIV counselling and testing services by a clinician or a trained health care practitioner.

 

4.3. "Counselling"

means counselling for HIV testing and is the process by which sufficient information about HIV is provided to the patients so they can give their explicit and voluntary informed consent to receive services. It must be confidential. Information provided during counselling can be to create awareness or detailed information about HIV.

 

4.4. "Directly assisted self-testing"

means when individuals who are self-testing for HIV receive an in-person demonstration from a trained provider or peer before or during HIVST.

 

4.5. "Empowered person"

means a person who has been counselled and believed to have understood the content of counselling and ready to make a decision whether to decline or accept the offer for testing.

 

4.6. "HIV"

means Human Immunodeficiency Virus.

 

4.7. "HIVST"

means HIV self-testing and is a process in which a person collects their own specimen and then performs a test and interprets the result.

 

4.8. "HIV workplace programmes"

means programmes which are specifically designed to mitigate the impact of HIV in the workplace. The programs are designed to create awareness towards making conscious choices through counselling and testing for HIV, linking individuals to treatment, monitoring of the disease and adherence counselling.

 

4.9. "HTS"

means all forms of HIV testing services.

 

4.10. "MITHAC"

means the mining industry TB and HIV advisory committee.

 

4.11. "Informed consent"

means a process of obtaining consent from a person to ensure that the person fully understands the nature, implications and future consequences of the HIV test before such person consents to take the test.

 

4.12. "NDOH"

means the South African National Department of Health.

 

4.13. "NDOH prequalified product"

means a quality assured product that have been approved for use in South Africa by the NDOH.

 

4.14. "Non-reactive self-screening results"

means a test result that does not show a reaction indicating the presence of analyte, which in the context of HIV refers to HIV- 1 P24 antigen or HIV-1/2 antibodies.

 

4.15. "PrEP"

means pre-exposure prophylaxis.

 

4.16. "Primary distribution method"

means when a self-screening kit is delivered directly to the end-user.

 

4.17. "Reactive self-screening results"

means a test result that shows a reaction indicating the presence of analyte, which in the context of HIV includes HIV-1 P24 antigen or HIV-1/2 antibodies.

 

4.18. "Secondary distribution method"

means when one or more self-screening kits are given to an individual, not for their own use, but to distribute to their sexual partner, family member or anyone in their network.

 

4.19. "Testing gap"

means a situation whereby individual(s) did not undergo HTS.

 

4.20. "Trained tester"

means to a health care professional/lay counsellor who has been trained to do the HIV testing in accordance with the WHO Guidelines on HIV self-testing and partner notification supplement to consolidated HIV test services.

 

4.21. "UNAIDS"

means the Joint United Nations Programme on HIV/AIDS.

 

4.22. "TB"

means tuberculosis

 

4.23. "Unassisted self-testing"

means when individuals self-test for HIV using only a self-test kit that includes manufacturer-provided instructions for use. As with all self-testing, users may be provided with links or contact details to access additional support, such as telephone hotlines or instructional videos.

 

4.24. "WHO"

means the World Health Organisation.